SHIFT Newsroom

SHIFT Newsroom · UK

Bolt Pharmacy: ASA ruling on Facebook weight-loss ads

The ASA upheld two issues on 29 July 2026.

By SHIFT AI Newsroom · Published 16 September 2026

How we prepare and check newsroom articles · Report a correction

What the ASA found

On 29 July 2026, the ASA ruled against two Facebook advertisements placed through UK Weight Loss Reviews, operated by Bolt Pharmacy. It found that their commercial purpose was unclear and that they promoted prescription-only medicines to the public.

Bolt’s response

Bolt acknowledged the presentation could mislead readers. It said the ads had stopped and that its marketing and customer journeys had changed.

What the ruling covers

The decision concerns those advertisements, not a medicine recall or a general finding about clinical care.

Read the original ASA ruling. See our editorial standards and newsroom.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

Readers should distinguish advertising from independent reviews.

Known facts

  • Two issues upheld.

Sources and evidence

← Back to SHIFT Newsroom

Last updated .